Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

The biopharmaceutical industry has traditionally focused on developing blockbuster drugs. However, over the past several years, a new era of drug development has unfolded. Personalized medicine and ...

While many people are suffering from Zoom fatigue and looking forward to in-person meetups, that isn’t really the case when it comes to HCPs and pharma reps. As with everyone, pharma reps were at a ...

Traws Pharma, Inc. (TRAW) has disclosed a new risk, in the Corporate Activity and Growth category. The integration of Onconova and Trawsfynydd poses a significant risk to Traws Pharma, Inc.’s future ...

After the U.S. tariff imposition, policymakers must diversify boldly, reform swiftly, and secure India’s pharma supremacy ...

The New York Times once called John Lamattina, then Pfizer head of R&D, “Dr. Optimistic.” He’s not so optimistic now.

With the business potentially at an important milestone, we thought we'd take a closer look at UroGen Pharma Ltd.'s (NASDAQ:URGN) future prospects. UroGen Pharma Ltd. engages in the development and ...

Why is it that one of the biggest bottlenecks in getting advanced drug therapies and vaccines to patients who need them most is not an issue with the funding, or the research, or a lack of ...

Where would we be if the so-called industry experts had been right — that it really would take five years to get to a vaccine? Historically, that has been typical, and the resulting vaccines have ...

Access to new-age medicines for obesity and diabetes is crucial for the Indian pharmaceutical industry's growth. Combined with AI tools, this will support accessibility and affordability. India aims ...

Based in Port Washington, Wis., Pharma-C-Wipes offers a variety of consumer products that include adult care, OTC and first aid. But the company has undergone some changes. AH: Innovation is a part of ...

Lumos Pharma (NASDAQ:LUMO) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of ...